The Latest Breaking News from AstraZeneca

Trevor Rees-Jones, Princess Diana’s former bodyguard and now head of security for AstraZeneca, was photographed outside a Morrisons store in Shropshire 25 years on from the fatal car crash

Futures fell sharply as the market rally pulls back. Elon Musk will hike Tesla FSD prices. Warren Buffett stock Occidental Petroleum surged Friday.

Pfizer (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD). The study met two co-primary objectives, associated with immunogenicity responses. Pfizer shares traded in a range of $48.55 to…

BALTIMORE — The tally of wasted COVID-19 vaccine continues to climb at the troubled Emergent BioSolutions plant in East Baltimore and now exceeds a half billion doses, according to findings a congressional panel released Thursday on the manufacturer once central to the U.S. coronavirus pandemic response.

In his first media interview since losing his Senate seat, Zed Seselja said he believed voters had made up their minds about the Morrison government before the election.

With climate change spurring more cases of tick-borne Lyme disease, drugmaker Valneva is betting big on a vaccine as it looks beyond disappointing sales of its COVID shot.

Here's a roundup of top developments in the biotech space over the last 24 hours:

AstraZeneca raised its full-year sales guidance on strength from its Covid drugs, leading AZN stock to inch higher early Friday.

The Anglo-Swedish pharmaceutical giant said it expects the Evusheld Covid-19 injection to help drive sales of at least 20% for the year.